Sarepta Therapeutics, Inc. (Nasdaq: SRPT) to Ring The Nasdaq Stock Market Closing Bell
September 05 2017 - 9:00AM
What: Sarepta Therapeutics,
Inc. (Nasdaq:SRPT), a commercial-stage biopharmaceutical company
focused on the discovery and development of precision genetic
medicines to treat rare neuromuscular diseases, will visit the
Nasdaq MarketSite in Times Square.
In recognition of World Duchenne Awareness Day, Douglas
Ingram, Sarepta’s President & CEO, will ring the
Closing Bell.
Where:Nasdaq MarketSite – 4 Times Square – 43rd
& Broadway – Broadcast Studio
When:Wednesday, September 6, 2017 – 3:45 p.m.
to 4:00 p.m. ET
Sarepta Therapeutics Contact:Ian Estepan(617)
274-4052iestepan@sarepta.com
Nasdaq MarketSite Media Contact:Emily Pan(646)
441-5120emily.pan@nasdaq.com
Feed Information:Fiber Line (Encompass
Waterfront): 4463
Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811 Vertical FEC
3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK
Social Media:For multimedia features such as
exclusive content, photo postings, status updates and video of bell
ceremonies, please visit our Facebook
page:http://www.facebook.com/NASDAQ.
For photos from ceremonies and events, please visit our
Instagram page:http://instagram.com/nasdaq
For livestream of ceremonies and events, please visit our
YouTube page:http://www.youtube.com/nasdaq/live
For news tweets, please visit our Twitter
page:http://twitter.com/nasdaq
For exciting viral content and ceremony photos, please visit our
Tumblr page:http://nasdaq.tumblr.com/
Webcast: A live stream of the Nasdaq Closing
Bell will be available at: https://new.livestream.com/nasdaq/live
or http://www.nasdaq.com/about/marketsitetowervideo.asx
Photos: To obtain a hi-resolution photograph of
the Market Close, please go to
http://business.nasdaq.com/discover/market-bell-ceremonies and
click on the market close of your choice.
About Sarepta TherapeuticsSarepta
Therapeutics is a commercial-stage biopharmaceutical company
focused on the discovery and development of precision genetic
medicines to treat rare neuromuscular diseases. The Company is
primarily focused on rapidly advancing the development of its
potentially disease-modifying Duchenne muscular dystrophy (DMD)
drug candidates. For more information, please
visit www.sarepta.com.
About Nasdaq:Nasdaq (Nasdaq:NDAQ) is a leading
global provider of trading, clearing, exchange technology, listing,
information and public company services. Through its diverse
portfolio of solutions, Nasdaq enables customers to plan, optimize
and execute their business vision with confidence, using proven
technologies that provide transparency and insight for navigating
today's global capital markets. As the creator of the world's first
electronic stock market, its technology powers more than 90
marketplaces in 50 countries, and 1 in 10 of the world's securities
transactions. Nasdaq is home to approximately 3,900 total listings
with a market value of approximately $12 trillion. To learn more,
visit: http://business.nasdaq.com
-NDAQA-
Sarepta Therapeutics (NASDAQ:SRPT)
Historical Stock Chart
From Apr 2024 to May 2024
Sarepta Therapeutics (NASDAQ:SRPT)
Historical Stock Chart
From May 2023 to May 2024